This is a definite sign of a merger! Koos will eventually merge and reduce the O/S! He is definitively hiding something BIG under his sleeve! There is no way in hell he is going to fund to trials of two drugs by increasing the O/S and more dilution! Doing so would send investors running out the door! This is 3rd quarter and we are about to rumble! Hold Tight!